Degradation of rapidly labelled RNA in proliferating and non-proliferating human acute leukemia cells

Experientia
A PileriF Gavosto

Abstract

No abstract listed.

References

Feb 1, 1967·The American Journal of Medicine·F MullinaxB Himrod
Nov 1, 1967·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F GavostoP Masera
Jul 4, 1964·Nature·F GavostoL PEGORARO
Dec 1, 1964·Experimental Cell Research·U TORELLIC MAURI

Citations

Related Concepts

Marrow
Leukemia
Lymphoid Leukemia
Acute Monocytic Leukemia
RNA, Neoplasm
Tritium
Uridine
Acute Myeloid Leukemia, M1

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.